Ambroxol, a cough medication, may help stabilize the neuropsychiatric symptoms of Parkinson's disease dementia, a new study ...

Parkinson's disease affects approximately 10 million people worldwide. It typically begins asymmetrically, initially ...

New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...

Scientists at the University of Sydney have uncovered a malfunctioning version of the SOD1 protein that clumps inside brain ...

An active ingredient in cough medicines since 1979 has shown promise as a treatment for neuropsychiatric symptoms in ...

Ambroxol is commonly used as an expectorant in cough syrup, helping thin out mucus so people with respiratory illnesses can ...

Parkinson’s disease often starts on one side of the body, and new research shows this asymmetry influences how non-motor symptoms progress.

Groundbreaking research by Sydney University found a new brain protein involved in Parkinson’s disease and a way to modify it ...

The results of experiments in mice models were "astounding," said biochemist Suzanne Pfeffer of Stanford University.

Ambroxol, long used for coughs in Europe, stabilized symptoms and brain-damage markers in Parkinson’s dementia patients over ...

Chinese scientists have discovered subtle new earlier signs of Parkinson’s in mice, an advance that may help diagnose the ...

Four compounds in ear canal secretions differ between those with and without Parkinson’s disease, suggesting they may be ...